20. May 2022

Zedira publication - Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease

Authors: Christian Büchold, Martin Hils, Uwe Gerlach, Johannes Weber, Christiane Pelzer, Andreas Heil, Daniel Aeschlimann, and Ralf Pasternack

This article is published in Cells’ Special Issue
Function of Transglutaminases in Adhesion Dynamics, Differentiation, and Cell Survival

The Open Access article is available for download:
Cells | Free Full-Text | Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease (mdpi.com)

Document

News

Blog

Events